This is the new MLex platform. Existing customers should continue to use the existing MLex platform until migrated.
For any queries, please contact Customer Services or your Account Manager. Dismiss

Facebook monopoly case brought in public interest, providing no basis to apply laches, states tell US court

( May 1, 2021, 01:48 GMT | Official Statement) -- MLex Summary: A group of states led by New York has filed a consent motion seeking permission to file a response to Facebook's notice of supplemental authority. In the filing, the states said a decision in the Reveal Chat Holdco v Facebook matter by another US district court "provides no basis whatsoever for applying laches" in the states' monopolization case against Facebook. In a filing to the US District Court for the District of Columbia, the states said that unlike private litigants, the states presumptively bring federal antitrust claims in the public interest. "In a case brought by a private entity, there might be a concern that the plaintiff is using antitrust litigation to harm a competitor or otherwise secure a market advantage; that concern simply is not present here," the filing said.See attached document....

Prepare for tomorrow’s regulatory change, today

MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.


Know what others in the room don’t, with features including:

  • Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
  • Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
  • Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
  • Curated case files bringing together news, analysis and source documents in a single timeline

Experience MLex today with a 14-day free trial.

Start Free Trial

Already a subscriber? Click here to login